Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-Wide Response to Antihypertensive Medication Using Home Blood Pressure Measurements: A Pilot Study Nested within the HOMED-BP Study

1 Nov 2013

Abstract excerpt

BACKGROUND: Patients with mild-to-moderate essential hypertension in the HOMED-BP trial were randomly allocated to first-line treatment with a calcium channel blocker (CCB), angiotensin-converting enzyme inhibitor (ACEI) or angiotensin II receptor blocker (ARB). METHODS: We recruited 265 (93 for CCB, 71 for ACEI and 101 for ARB) patients who completed the genomic study. Home blood pressure was measured for 5 days...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Associations and Epidemiology
Share to Pharmacogenetics and Drug Metabolism
Share to Renin-Angiotensin System Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24192120
DOI: 10.2217/pgs.13.161

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-Wide Response to Antihypertensive Medication Using Home Blood Pressure Measurements: A Pilot Study Nested within the HOMED-BP StudyPMID 24192120Read ↗

Novel and Known Genetic Players in Hypertension: From Gene Expression to Striking InsightsSemantic proximity Read ↗

Advancing management of hypertension through pharmacogenomicsSemantic proximity Read ↗

Hypertension precision medicine: the promise and pitfalls of pharmacogenomicsSemantic proximity Read ↗

Calcium Channel Blockers: clinical outcome associations with reported pharmacogenetics variants in 32,000 patientsSemantic proximity Read ↗

Pharmacogenomics of hypertension: a genome‐wide, placebo‐controlled cross‐over study, using four classes of antihypertensive drugs.Semantic proximity Read ↗

Pharmacogenomics And Hypertension: Current InsightsSemantic proximity Read ↗

Assessing the efficacy and safety of angiotensinogen inhibition using human geneticsSemantic proximity Read ↗

Association of hypertension drug target genes with blood pressure and hypertension in 86,588 individuals.Semantic proximity Read ↗

Combining pharmacogenetics and patient characteristic polygenic scores to improve outcome prediction for Calcium Channel Blocker treatmentSemantic proximity Read ↗

Pharmacogenomics of Hypertension: A Genome‐Wide, Placebo‐Controlled Cross‐Over Study, Using Four Classes of Antihypertensive DrugsSemantic proximity Read ↗

Pharmacoepigenetics of hypertension: genome-wide methylation analysis of responsiveness to four classes of antihypertensive drugs using a double-blind crossover study designSemantic proximity Read ↗

Pharmacogenomics of amlodipine and hydrochlorothiazide therapy and the quest for improved control of hypertension: a mini reviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.